BRISBANE, CALIFORNIA, Aug. 03, 2023 GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company s proprietary natural killer .
BRISBANE, CALIFORNIA, Aug. 03, 2023 (GLOBE NEWSWIRE) GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing.
GT Biopharma to Participate in the H C Wainwright Immune Cell Engager Conference on August 17, 2023 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
GT Biopharma to Participate in the H C Wainwright Immune Cell Engager Conference on August 17, 2023 itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Presentation shows the therapeutic potential of combining iPSC-derived CAR NK cells and NK cell engagers to overcome the clinical heterogeneity of AML .